U.S. Pharma Stock News

General Motors stock has delivered a 133.9% return over the past three years, yet the valuation picture remains split, with the Discounted Cash Flow (DCF) intrinsic value pointing to upside while traditional market multiples suggest the shares are not obviously cheap. A 133.9% gain over three years puts General Motors among the stronger performers in its peer group and raises the question of how much of that progress is already reflected in the price. Recent news on higher earnings...

Masimo recently received FDA 510(k) clearance for its Patient State Index (PSi) for pediatric patients, enabling age-calibrated brain function monitoring for children four years and older in operating rooms and intensive care units. This clearance introduces the first sedation index specifically tailored to pediatric brain physiology and derived from bilateral EEG data, potentially setting a new clinical benchmark versus adult-focused competitor systems. We’ll now examine how this...

Constellium (NYSE:CSTM) heads into its Q2 2026 earnings release on July 29, with attention on how robust demand and higher metal prices may balance against rising input costs and foreign exchange pressures. See our latest analysis for Constellium. At a share price of $29.51, Constellium has seen strong year to date share price momentum of 49.27%, even though the 30 day share price return declined 7.14%. The 1 year total shareholder return of 111.84% and 5 year total shareholder return of...

In recent months, Himax Technologies has rolled out its HE Series indirect Time-of-Flight depth decoder chips, expanding its display and imaging portfolio into AI vision and robotics applications. This launch, alongside the company’s ultra-low power sensing, microdisplay, and nano-optics capabilities for smart glasses and AR, is sharpening investor focus on Himax’s role in next-generation devices. We’ll now examine how the new Time-of-Flight chips might influence Himax’s investment narrative...

Bank of Hawaii (BOH) has reported a solid Q2 2026 result, with revenue of US$193.3 million and EPS of US$1.48, supported by trailing twelve month revenue of US$751.2 million and EPS of US$5.42. The company’s revenue increased from US$171.2 million in Q2 2025 to US$193.3 million in Q2 2026, while EPS over the same quarters rose from US$1.07 to US$1.48, setting this latest report against a year of stronger profitability and firmer net margins. See our full analysis for Bank of Hawaii. With the...

In July 2026, ConnectOne Bank announced it had deployed nCino's embedded AI capabilities across its commercial lending operations, using Banking Advisor and custom agents to sharply cut time spent on document search and relationship updates. The bank reports that document search tasks now take as little as 30 seconds instead of 20 minutes and has seen rapid user adoption, offering a tangible example of how nCino's AI tools can reshape day-to-day banking workflows. Now we will examine how...

Election headlines are once again in the driver’s seat, and the latest legal push by the Trump administration around mail-in voting is adding a fresh source of uncertainty just 99 days before the midterms. For investors, sharper swings in sentiment can mean heavier trading volumes and wider price moves across the market. That is where exchange operators and trading platforms often come into focus, as they sit at the center of this activity. This article walks through 3 stocks exposed to the...

Herc Holdings (HRI) is back in focus as the equipment rental company reports Q2 2026 results before the market opens today. This will be followed by its earnings call, giving investors fresh data on recent trading. See our latest analysis for Herc Holdings. At a latest share price of US$160.0, Herc Holdings has seen its 7 day share price return rise 8.58% and its 90 day share price return reach 19.44%. The 5 year total shareholder return of 44.65% points to a stock that has rewarded patient...

Why Omnicom Group’s Upcoming Earnings Are Back in Focus Investor interest in Omnicom Group (OMC) has picked up ahead of its upcoming earnings announcement, with the market expecting revenue growth of 60.4% year on year following a 4.2% change in the same quarter last year. Analysts have largely kept their forecasts steady over the past month. This points to expectations for a relatively consistent operational picture as shareholders watch how the stock trades into and after the results. See...

Northwest Bancshares, Inc. has now reported its Q2 2026 results, with net interest income rising to US$146.94 million and net income to US$53.55 million, alongside a quarterly cash dividend of US$0.20 per share for its 127th consecutive dividend payment. The quarter’s strong earnings beat, supported by higher net interest margin, solid loan growth, and stable credit quality, highlights operational efficiency and balance sheet resilience. Next, we’ll examine how this earnings beat and...

Fastenal Company recently reported second-quarter 2026 results showing higher sales of US$2,386.9 million and net income of US$382.8 million, alongside a new director appointment and an ESOP-related shelf registration for 8,500,000 common shares worth US$385.56 million. Together with a new cash dividend and ongoing share repurchases, these moves highlight how Fastenal is balancing employee ownership, governance refresh, and capital returns. We’ll now examine how this stronger quarterly...

Rollins, Inc. has already reported its second-quarter 2026 results, posting net income of US$143.91 million and diluted EPS of US$0.30, alongside affirming a quarterly dividend of US$0.1825 per share payable on September 10, 2026. The modest year-over-year earnings increase, combined with the maintained dividend, highlights the company’s focus on both profitability and ongoing cash returns to shareholders. With Q2 earnings showing only a slight uptick in net income, we’ll now examine how...

ON Semiconductor (ON) is back in focus as investors look ahead to its August 3 quarterly report, with expectations for higher revenue and earnings for the June 2026 period. See our latest analysis for ON Semiconductor. ON Semiconductor's share price has climbed 57.04% year to date to $89.04, while the 1 year total shareholder return of 51.79% contrasts with a 3 year total shareholder return that is down 17.36%. This suggests strong recent momentum after a weaker stretch. If ON Semiconductor's...

Legal shockwaves from Johnson & Johnson’s proposed $5.5b talc settlement are rippling through the baby care and personal health space, reshaping how investors think about litigation risk, consumer trust, and competitive positioning. With up to $3b potentially paid out in the next year and no further payments scheduled before 2028, this attempt to resolve around 69,000 talc-related lawsuits could mark a turning point for Johnson & Johnson and its peers. Below, you will see 3 stocks exposed to...

Palantir Technologies (PLTR) heads into its upcoming earnings report with expectations shaped by rising demand for its AI software, renewed U.S. government interest, and recent participation in high profile AI alliances. See our latest analysis for Palantir Technologies. Recent headlines around Palantir Technologies, from the renewed U.S. Small Business Administration fraud detection work to fresh AI alliance activity, have arrived alongside a 16.47% 30 day share price return. At the same...

Mattel (MAT) is back in the spotlight after Barbie introduced a signature doll modeled on basketball star and entrepreneur Angel Reese, paired with co-branded Reebok footwear and apparel that extends Barbie’s reach into sports culture. See our latest analysis for Mattel. Despite the recent Barbie x Angel Reese spotlight and fresh licensing moves with WWE and 7-Eleven collaborations, Mattel’s recent 1 day and 30 day share price returns of 3.21% and 5.87% sit against a year to date share price...

Recently, Ondas Holdings announced an acceleration of defense contract wins alongside a new investment in FPF Defense, which is developing autonomous counter-drone systems and relocating its headquarters to West Palm Beach to build a broader defense technology hub with Ondas. This move deepens Ondas’ exposure to autonomous defense solutions aimed at addressing cost asymmetry in drone defense, aligning closely with its existing focus on private wireless and drone technologies. We’ll now...

What Restaurant Brands International Stock Offers Investors Right Now Restaurant Brands International (NYSE:QSR) runs several large quick service restaurant chains and gives investors exposure to coffee, burgers, chicken and sandwich concepts across Canada, the United States and other international markets. The stock recently closed at US$74.41, with reported annual revenue of US$9.59b and net income of US$1.08b. This positions Restaurant Brands International as a sizeable player in global...

Grand Canyon Education (LOPE) has drawn fresh attention after recent share moves, with the stock roughly flat over the past month but down about 14% in the past 3 months. See our latest analysis for Grand Canyon Education. At a share price of $144.86, Grand Canyon Education has recently seen short term momentum pick up, with the 1 day share price return of 3.52% and 7 day share price return of 3.87% set against a weaker 1 year total shareholder return of 13.36% and stronger 3 and 5 year total...

Earlier in July 2026, Equinix, Inc. confirmed the planned departure of Chief Business Officer Jon Lin and outlined a transition plan distributing his responsibilities across the senior leadership team while preparing to appoint a new Chief Product Officer. Shortly afterward, the company named Chris Audie as Chief Product Officer and Bruce Owen as Executive Vice President, Global Markets, underscoring a sharpened focus on product innovation and global operations alignment. Next, we’ll examine...

Sarepta Therapeutics has appointed Michael Severino, M.D., a veteran of AbbVie, Amgen, Merck and most recently Tessera Therapeutics, as its Chief Executive Officer effective July 28, 2026, succeeding Douglas Ingram. By combining the CEO role with a seat on Sarepta’s board, Severino’s broad R&D and corporate strategy background could shape how the company prioritizes its gene therapy and RNA-based rare disease programs. Next, we’ll explore how bringing former AbbVie president Michael Severino...

After a 37.8% return over the past year, Best Buy stock no longer looks like an obvious bargain, and the current checks suggest pricing that is roughly in line with what its fundamentals support rather than clearly cheap or clearly expensive. The 37.8% one year gain puts recent shareholders in a strong position, which can make fresh entries more sensitive to what is already baked into the price. Leadership changes, including a new CEO and a chief fulfillment and operations officer focused on...

Rigetti Computing announced a partnership with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center to build TangleLab, a hybrid quantum‑classical supercomputing testbed at PSC, funded by a US$5.0 million National Science Foundation grant and scheduled to begin construction in 2026 with full operations targeted for 2027. This collaboration embeds Rigetti’s 9‑qubit Novera system in an open, federally backed research and education platform, potentially deepening its role in...

Earlier in July 2026, ACADIA Pharmaceuticals announced that the FDA granted Fast Track designation to remlifanserin, its investigational 5-HT2A inverse agonist for hallucinations and delusions in Alzheimer’s disease psychosis, alongside progress updates on the seamless Phase 2/3 RADIANT program. This designation, coupled with ongoing Phase 3 enrollment, highlights how remlifanserin could meaningfully expand ACADIA’s late-stage CNS portfolio beyond its current commercial drugs. Next, we’ll...